454 related articles for article (PubMed ID: 34761592)
41. Hsa_circ_0000190 Promotes NSCLC Cell Resistance to Cisplatin via the Modulation of the miR-1253/IL-6 Axis.
He H; Li T
Anal Cell Pathol (Amst); 2024; 2024():6647810. PubMed ID: 38440120
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300.
Ding L; Li L; Tang Z
Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026
[TBL] [Abstract][Full Text] [Related]
43. CircRNA B cell linker regulates cisplatin sensitivity in nonsmall cell lung cancer via microRNA-25-3p/BarH‑like homeobox 2 axis.
Liu Y; Hu Y; Zhao C; Lu Q
Anticancer Drugs; 2023 Jun; 34(5):640-651. PubMed ID: 36602424
[TBL] [Abstract][Full Text] [Related]
44. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
Hu S; Zhang Q; Sun J; Xue J; Wang C
Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
[TBL] [Abstract][Full Text] [Related]
45. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C
Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206
[TBL] [Abstract][Full Text] [Related]
46. Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
Wei H; Li L; Zhang H; Xu F; Chen L; Che G; Wang Y
Cell Cycle; 2021 Jan; 20(2):166-178. PubMed ID: 33413028
[TBL] [Abstract][Full Text] [Related]
47. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
Gao Y; Huang Y
J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
[TBL] [Abstract][Full Text] [Related]
48. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
Liu Y; Zhang Y; Li Q; Xu R; Huang N
Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
[TBL] [Abstract][Full Text] [Related]
49. Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression.
Zhang J; Cui X; Qu H; Zhang Y
J Chemother; 2023 Oct; 35(6):550-562. PubMed ID: 36591727
[TBL] [Abstract][Full Text] [Related]
50. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.
Liu L; Zhang Q; Peng H
J Chemother; 2023 Feb; 35(1):39-52. PubMed ID: 35289739
[TBL] [Abstract][Full Text] [Related]
51. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
[TBL] [Abstract][Full Text] [Related]
52. Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis.
Ling Q; Wu S; Liao X; Liu C; Chen Y
BMC Cancer; 2022 Jul; 22(1):765. PubMed ID: 35836137
[TBL] [Abstract][Full Text] [Related]
53. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
[TBL] [Abstract][Full Text] [Related]
54. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
Wang L; Shang X; Feng Q
Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
[TBL] [Abstract][Full Text] [Related]
55. CircRNA hsa_circ_0075048 promotes the malignant progression of non-small cell lung cancer by up-regulating HMGB2 expression via targeting miR-1225-5p.
Zhang J; Mao J
Histol Histopathol; 2023 Jun; 38(6):709-724. PubMed ID: 36416408
[TBL] [Abstract][Full Text] [Related]
56. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
Sheng H; Wang X
Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
[TBL] [Abstract][Full Text] [Related]
57. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9.
Liu B; Wang R; Liu H
Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989
[TBL] [Abstract][Full Text] [Related]
58. Circ-SNAP47 (hsa_circ_0016760) and miR-625-5p are regulators of WEE1 in regulation of chemoresistance, growth and invasion of DDP-tolerant NSCLC cells via ceRNA pathway.
Zou C; Rong F; Zeng Y; Zeng J; Wei R; Wei D
Environ Toxicol; 2022 Feb; 37(2):224-236. PubMed ID: 34664776
[TBL] [Abstract][Full Text] [Related]
59. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior.
Zhu X; Wan J; You X; Yang W; Zhao L
Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
[TBL] [Abstract][Full Text] [Related]
60. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
Yang B; Zhang B; Qi Q; Wang C
BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
